National Nutrition and Food Technology Institute
Dr Azita Hekmatdoost
In this randomized clinical trial, patients with diabetes will be randomly assigned to receive either Berberine, and Cinnamon supplements or placebo for 12 weeks. Then the glycemic characteristics will be compared in two groups.
Diabetes
Berberine+Cinnamon
Placebo
Phase 2
Phase 3
| Study Type : | Interventional |
| Estimated Enrollment : | 42 participants |
| Masking : | Triple |
| Primary Purpose : | Treatment |
| Official Title : | The Effects of Berberine and Cinnamon Supplementation on Diabetes Management |
| Actual Study Start Date : | November 1, 2022 |
| Estimated Primary Completion Date : | February 1, 2023 |
| Estimated Study Completion Date : | February 10, 2023 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Intervention |
Dietary Supplement: Berberine+Cinnamon |
|
Placebo Comparator: Placebo |
Other: Placebo |
| Ages Eligible for Study: | 20 Years to 65 Years |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.